Berman Capital Advisors’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
$113K Sell
591
-50
-8% -$10.1K 0.02% 403
2021
Q2
$135K Buy
641
+8
+1% +$1.69K 0.02% 310
2021
Q1
$128K Buy
633
+127
+25% +$25K 0.03% 254
2020
Q4
$91K Buy
506
+10
+2% +$1.7K 0.02% 265
2020
Q3
$83K Buy
496
+32
+7% +$5.39K 0.02% 253
2020
Q2
$74K Sell
464
-30
-6% -$5.38K 0.02% 268
2020
Q1
$85K Sell
494
-114
-19% -$22.7K 0.03% 221
2019
Q4
$121K Buy
608
+224
+58% +$46K 0.03% 200
2019
Q3
$81K Buy
384
+12
+3% +$2.51K 0.03% 236
2019
Q2
$72K Buy
372
+30
+9% +$5.53K 0.02% 250
2019
Q1
$56K Buy
342
+66
+24% +$11.7K 0.02% 259
2018
Q4
$51K Buy
+276
New +$51K 0.02% 248

Other funds holding CME

Berman Capital Advisors's CME Position: Q3 2021 in Review

Berman Capital Advisors reduced its CME Group (CME) stake by 7.8% in Q3 2021, selling an estimated $10.1K and leaving 591 shares worth $113K. The position accounts for 0.02% of the portfolio, ranked #403.

Berman Capital Advisors first reported a position in CME in Q4 2018 and has held it in 12 quarters since. The position peaked at $135K in Q2 2021. 1,055 funds tracked by Wall St. Rank hold CME as of Q3 2021.

  • Berman Capital Advisors held 591 shares of CME Group worth $113K as of Q3 2021.
  • Berman Capital Advisors sold 50 CME Group shares in Q3 2021, an estimated $10.1K.
  • CME Group made up 0.02% of Berman Capital Advisors's portfolio in Q3 2021, its #403 holding.
  • Berman Capital Advisors first reported a position in CME Group in Q4 2018 and has held it in 12 quarters since.
  • Berman Capital Advisors's CME Group position peaked at $135K in Q2 2021.
  • 1,055 funds tracked by Wall St. Rank held CME Group as of Q3 2021.

Based on Berman Capital Advisors's 13F filing for Q3 2021, filed 7 Oct 2021.